Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2012-08-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Undernourished Pregnant Women
Pregnant women who are classified as undernourished
No interventions assigned to this group
Nourished Pregnant Women
Pregnant women who are classified as healthy
No interventions assigned to this group
Overweight/obese Pregnant women
Pregnant women who are classified as obese or overweight
No interventions assigned to this group
Undernourished + Yogurt Pregnant Women
Pregnant women who are undernourished and selected to receive Moringa and Lactobacillus rhamnosus GR-1 probiotic yogurt. Yogurt contained 4.3 grams of Moringa and 10\^8 CFU/mL of Lactobacillus rhamnosus GR-1 as well as Streptococcus thermophilus and Lactobacillus bulgaricus starter cultures.
Moringa and Lactobacillus rhamnosus GR-1
Nourished + Yogurt Pregnant Women
Pregnant women who are healthy and selected to receive Moringa and Lactobacillus rhamnosus GR-1 probiotic yogurt. Yogurt contained 4.3 grams of Moringa and 10\^8 CFU/mL of Lactobacillus rhamnosus GR-1 as well as Streptococcus thermophilus and Lactobacillus bulgaricus starter cultures.
Moringa and Lactobacillus rhamnosus GR-1
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moringa and Lactobacillus rhamnosus GR-1
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between the ages of 18 and 40 years
Exclusion Criteria
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Medical Research, Tanzania
OTHER_GOV
Western University, Canada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Gregor Reid
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregor Reid, BSc Hons PhD MBA ARM CCM Dr HS
Role: PRINCIPAL_INVESTIGATOR
Western University, Canada; Lawson Health Research Institute
Jeremy P Burton, Phd
Role: PRINCIPAL_INVESTIGATOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nyerere Dispensary
Buswelu, , Tanzania
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bisanz JE, Enos MK, Mwanga JR, Changalucha J, Burton JP, Gloor GB, Reid G. Randomized open-label pilot study of the influence of probiotics and the gut microbiome on toxic metal levels in Tanzanian pregnant women and school children. mBio. 2014 Oct 7;5(5):e01580-14. doi: 10.1128/mBio.01580-14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
102400
Identifier Type: -
Identifier Source: org_study_id